Drug Profile
Anti-TGF-beta monoclonal antibody 2G7
Alternative Names: Anti-TGF-beta 2G7; Anti-TGF-beta antibody 2G7; Anti-transforming growth factor-beta monoclonal antibody 2G7Latest Information Update: 15 Aug 2002
Price :
$50
*
At a glance
- Originator Genentech
- Developer Genentech; Nonindustrial source
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Transforming growth factor beta inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer